News & Events about Essa Pharma Inc.
ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) Research analysts at Oppenheimer issued their Q1 2024 earnings per share (EPS) estimates for ESSA Pharma in a note issued to investors on Tuesday, February 7th. Oppenheimer analyst M. Breidenbach expects that the company will post ...
Thinking about buying stock in ESSA Pharma, Meta Platforms, Nio, Quanergy Systems, or Alphabet? Thinking about buying stock in ESSA Pharma, Meta Platforms, Nio, Quanergy Systems, or Alphabet? PR Newswire NEW YORK, Oct. 28, 2022 NEW YORK, Oct. 28, 2022 /PRNewswire/ -- InvestorsObserverissues...
Woodline Partners LP increased its stake in shares of ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) by 286.6% in the 4th quarter, HoldingsChannel reports. The firm owned 684,247 shares of the companys stock after buying an additional 507,239 shares during the quarter. Woodline Partners LPs ...
Ticker Report
9 months ago
Woodline Partners LP grew its stake in ESSA Pharma Inc. (NASDAQ:EPIX Get Rating) (TSX:EPI) by 286.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 684,247 shares of the companys ...
ESSA Pharma (NASDAQ:EPIX Get Rating) (TSX:EPI) had its price objective lowered by Piper Sandler from $50.00 to $20.00 in a research report released on Thursday, The Fly reports. EPIX stock opened at $5.91 on Thursday. ESSA Pharma has a 52 week low of $5.22 and a 52 week high of $36.00. The company ...